RCKT

NASDAQ open

Rocket Pharmaceuticals

2.09 USD
▼-0.02-0.95%
盘后 2.40 0.00%
2026-11-20
市值
$217.74M
市盈率
—
EPS
-0.14
股息率
—
52 周区间
2.03 – 5.45
成交量
666.32K
Beta
0.49
目标价
8.31
52W 低 2.0352W 高 5.45
价格走势

公司简介

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardia...